We are live on ! Find out more

371 hedge funds and large institutions have $14B invested in Incyte in 2016 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 149 increasing their positions, 126 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 32

43% more call options, than puts

Call options by funds: $75.9M | Put options by funds: $53M

18% more repeat investments, than reductions

Existing positions increased: 149 | Existing positions reduced: 126

8% more capital invested

Capital invested by funds: $13B → $14B (+$1.05B)

3% more funds holding

Funds holding: 359371 (+12)

11% less funds holding in top 10

Funds holding in top 10: 98 (-1)

Holders
371
Holders Change
+12
Holders Change %
+3.34%
% of All Funds
9.88%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.21%
New
48
Increased
149
Reduced
126
Closed
32
Calls
$75.9M
Puts
$53M
Net Calls
+$22.9M
Net Calls Change
-$20.4M

INCY Hedge Fund Activity: Q2 2016 in Review

371 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Incyte (INCY) for Q2 2016, worth a combined $14B — up 8.1% from $13B a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new INCY positions and 32 closed out — a net gain of 16 holders — while 149 added to existing stakes and 126 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $63.4M. The largest seller was T. Rowe Price Associates, cutting an estimated $298M.

  • 371 institutional investors held Incyte (INCY) as of Q2 2016, up from 359 in Q1 2016.
  • Funds reported $14B of Incyte stock for Q2 2016, up 8.1% quarter-over-quarter.
  • 48 funds opened new Incyte positions in Q2 2016 and 32 closed out, a net change of +16 holders.
  • The largest Incyte buyer in Q2 2016 was Citadel Advisors, an estimated $63.4M added.
  • The largest Incyte seller in Q2 2016 was T. Rowe Price Associates, an estimated $298M sold.

Based on aggregated 13F filings for Q2 2016.